Inventor
BRESLIN HENRY JOSEPH
US14 patents
⚠️ This page may combine multiple inventors who share the name “BRESLIN HENRY JOSEPH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
7 patentsUS7125891B2Oct 24, 2006
Tripeptidyl peptidase inhibitors
JANSSEN PHARMACEUTICA NV18 citations92
US7943635B2May 17, 2011
Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
JANSSEN PHARMACEUTICA NV7 citations84
US7241777B2Jul 10, 2007
Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
JANSSEN PHARMACEUTICA NV14 citations84
US7511061B2Mar 31, 2009
Triazoles as farnesyl transferase inhibitors
JANSSEN PHARMACEUTICA NV2 citations61
US7947713B2May 24, 2011
Tripeptidyl peptidase inhibitors
JANSSEN PHARMACEUTICA NV1 citations51
US7592356B2Sep 22, 2009
Triazoles as farnesyl transferase inhibitors
JANSSEN PHARMACEUTICA NV0 citations51
US6201119B1Mar 13, 2001
Antiretroviral tetrahydroimidazo[1,4]benzodiazepin-2(thi) ones
JANSSEN PHARMACEUTICA NV0 citations51
Atrin Pharmaceuticals LLC
4 patentsUS9663535B2May 30, 2017
Ataxia telengiectasia and Rad3-related (ATR) protein kinase inhibitors
Atrin Pharmaceuticals LLC9 citations78
US10196405B2Feb 5, 2019
Ataxia telengiectasia and Rad3-related (ATR) protein kinase inhibitors
Atrin Pharmaceuticals LLC0 citations46
US9981989B2May 29, 2018
Ataxia telengiectasia and Rad3-related (ATR) protein kinase inhibitors
Atrin Pharmaceuticals LLC0 citations46
US10301324B2May 28, 2019
Ataxia telengiectasia and rad3-related (ATR) inhibitors and methods of their use
Atrin Pharmaceuticals LLC0 citations34